The loss, compared with an operating gain of $52.6 million in 2021, resulted in a $95.3 million swing over one year. Declining investment returns dragged the overall loss in 2022 down to $169.6 million compared with net income of $134 million in 2021.
Inspira Health reported long-term debt of $480.5 million at the end of 2022.
The three-hospital system named its first female board chair, effective April 5, with the appointment of Elizabeth Ryan. William Pelion was named senior vice president and CFO on March 13.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
